By participating in the BOTOX® Savings Program, you acknowledge and agree to the full Terms & Conditions set out at BOTOXSavingsProgram.com/TermsandConditions. Patients enrolled in Medicare, Medicaid, TRICARE, or any other government-reimbursed healthcare program are not eligible. Other restrictions and maximum limits apply.
*Eligibility: Available to patients with commercial insurance coverage for BOTOX® (onabotulinumtoxinA) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions visit abbv.ie/bsp-terms or call 1-800-44-BOTOX (800-442-6869) for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
LEARN MOREBOTOX® is a proven option for severe underarm sweating when antiperspirants fail. Treatment can last up to 201 days—that’s 6.7 months. Individual results may vary.
Your dermatologist will make 10 to 15 small injections into the affected underarm area through a very fine needle.1 You should notice a significant reduction in underarm sweating within 4 weeks of your first treatment.1 If you do not see a significant reduction in sweating, you should contact your dermatologist and request a follow-up consultation.
You can experience drier underarms for up to 201 days or 6.7 months.1 Individual results may vary.
Keep in mind that BOTOX® is not a cure for severe underarm sweating. Your symptoms will return gradually, and you’ll know when the time is right for another treatment.1 Your healthcare provider can recommend a treatment strategy.
INDICATION
BOTOX® (onabotulinumtoxinA) is a prescription medicine that is injected into the skin to treat the symptoms of severe underarm sweating (severe primary axillary hyperhidrosis) when medicines used on the skin (topical) do not work well enough in people 18 years and older.
It is not known whether BOTOX is safe and effective for severe sweating anywhere other than your armpits.
IMPORTANT SAFETY INFORMATION
BOTOX may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX:
There has not been a confirmed serious case of spread of toxin effect away from the injection site when BOTOX has been used at the recommended dose to treat severe underarm sweating.
BOTOX may cause loss of strength or general muscle weakness, vision problems, or dizziness within hours to weeks of receiving BOTOX. If this happens, do not drive a car, operate machinery, or do other dangerous activities.
Do not receive BOTOX if you are allergic to any of the ingredients in BOTOX (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB), Dysport® (abobotulinumtoxinA), Xeomin® (incobotulinumtoxinA), Jeuveau® (prabotulinumtoxinA-xvfs), Daxxify® (daxibotulinumtoxinA-lanm), or Letybo® (letibotulinumtoxinA-wlbg) (this may not be a complete list of all botulinum toxin products); have a skin infection at the planned injection site.
The dose of BOTOX is not the same as, or comparable to, another botulinum toxin product.
Serious and/or immediate allergic reactions have been reported, including itching; rash; red, itchy welts; wheezing; asthma symptoms; dizziness; or feeling faint. Get medical help right away if you experience symptoms; further injection of BOTOX should be discontinued.
Tell your doctor about all your muscle or nerve conditions, such as ALS or Lou Gehrig’s disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at increased risk of serious side effects, including difficulty swallowing and difficulty breathing from typical doses of BOTOX.
Tell your doctor about all your medical conditions, including if you have or have had bleeding problems; have plans to have surgery; had surgery on your face; have weakness of forehead muscles, trouble raising your eyebrows, drooping eyelids, and any other abnormal facial change; are pregnant or plan to become pregnant (it is not known if BOTOX can harm your unborn baby); are breastfeeding or plan to (it is not known if BOTOX passes into breast milk).
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your doctor that you have received BOTOX in the past.
Tell your doctor if you received any other botulinum toxin product in the last 4 months; have received injections of botulinum toxin such as Myobloc®, Dysport®, Xeomin®, Jeuveau®, Daxxify®, or Letybo® in the past (this may not be a complete list of all botulinum toxin products; tell your doctor exactly which product you received); have recently received an antibiotic by injection; take muscle relaxants; take an allergy or cold medicine; take a sleep medicine; take aspirin-like products or blood thinners.
Other side effects of BOTOX include dry mouth; discomfort or pain at the injection site; tiredness; headache; neck pain; eye problems such as double vision, blurred vision, decreased eyesight, drooping eyelids, swelling of your eyelids, and dry eyes; drooping eyebrows; and upper respiratory tract infection.
For more information refer to the Medication Guide or talk with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see BOTOX® full Product Information, including Boxed Warning and Medication Guide, at https://www.rxabbvie.com/pdf/botox_pi.pdf and discuss with your doctor.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.
References: 1. BOTOX® Prescribing Information, November 2023. 2. U.S. National Library of Medicine. National Institutes of Health (NIH). MedlinePlus website. http://www.nlm.nih.gov/medlineplus/ency/article/007259.htm. Updated June 7, 2023. Accessed January 10, 2025. 3. U.S. National Library of Medicine. National Institutes of Health (NIH). MedlinePlus website. http://www.nlm.nih.gov/medlineplus/ency/article/003218.htm. Updated June 20, 2023. Accessed January 10, 2025. 4. Solish N, Bertucci V, Dansereau A, et al. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg. 2007;33(8):908-923. 5. American Academy of Dermatology (AAD). Hyperhidrosis: Diagnosis and treatment. AAD website. https://aad.org/public/diseases/dry-sweaty-skin/hyperhidrosis. Accessed January 10, 2025. 6. International Hyperhidrosis Society. OnabotulinumtoxinA Injections (BOTOX®). International Hyperhidrosis Society website. https://sweathelp.org/hyperhidrosis-treatments/botox.html. Updated 2014. Accessed January 05, 2025.
© 2025 AbbVie. All rights reserved. BOTOX® and its design are registered trademarks of Allergan, Inc., an AbbVie company. All other trademarks are the property of their respective owners.
US-BNO-250017
This site is intended for US consumers only. No information on this site is provided with the intention to give medical advice or instructions on the accurate use of AbbVie products. AbbVie cannot answer unsolicited emails requesting personal medical advice; visitors should always consult a healthcare professional. Please visit the AbbVie site of your country of residence for information concerning AbbVie products and services available there.
INDICATION
BOTOX® (onabotulinumtoxinA) is a prescription medicine that is injected into the skin to treat the symptoms of severe underarm sweating (severe primary axillary hyperhidrosis) when medicines used on the skin (topical) do not work well enough in people 18 years and older.
It is not known whether BOTOX is safe and effective for severe sweating anywhere other than your armpits.
IMPORTANT SAFETY INFORMATION
BOTOX may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX:
There has not been a confirmed serious case of spread of toxin effect away from the injection site when BOTOX has been used at the recommended dose to treat severe underarm sweating.
BOTOX may cause loss of strength or general muscle weakness, vision problems, or dizziness within hours to weeks of receiving BOTOX. If this happens, do not drive a car, operate machinery, or do other dangerous activities.
Do not receive BOTOX if you are allergic to any of the ingredients in BOTOX (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB), Dysport® (abobotulinumtoxinA), Xeomin® (incobotulinumtoxinA), Jeuveau® (prabotulinumtoxinA-xvfs), Daxxify® (daxibotulinumtoxinA-lanm), or Letybo® (letibotulinumtoxinA-wlbg) (this may not be a complete list of all botulinum toxin products); have a skin infection at the planned injection site.
The dose of BOTOX is not the same as, or comparable to, another botulinum toxin product.
Serious and/or immediate allergic reactions have been reported, including itching; rash; red, itchy welts; wheezing; asthma symptoms; dizziness; or feeling faint. Get medical help right away if you experience symptoms; further injection of BOTOX should be discontinued.
Tell your doctor about all your muscle or nerve conditions, such as ALS or Lou Gehrig’s disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at increased risk of serious side effects, including difficulty swallowing and difficulty breathing from typical doses of BOTOX.
Tell your doctor about all your medical conditions, including if you have or have had bleeding problems; have plans to have surgery; had surgery on your face; have weakness of forehead muscles, trouble raising your eyebrows, drooping eyelids, and any other abnormal facial change; are pregnant or plan to become pregnant (it is not known if BOTOX can harm your unborn baby); are breastfeeding or plan to (it is not known if BOTOX passes into breast milk).
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your doctor that you have received BOTOX in the past.
Tell your doctor if you received any other botulinum toxin product in the last 4 months; have received injections of botulinum toxin such as Myobloc®, Dysport®, Xeomin®, Jeuveau®, Daxxify®, or Letybo® in the past (this may not be a complete list of all botulinum toxin products; tell your doctor exactly which product you received); have recently received an antibiotic by injection; take muscle relaxants; take an allergy or cold medicine; take a sleep medicine; take aspirin-like products or blood thinners.
Other side effects of BOTOX include dry mouth; discomfort or pain at the injection site; tiredness; headache; neck pain; eye problems such as double vision, blurred vision, decreased eyesight, drooping eyelids, swelling of your eyelids, and dry eyes; drooping eyebrows; and upper respiratory tract infection.
For more information refer to the Medication Guide or talk with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see BOTOX® full Product Information, including Boxed Warning and Medication Guide, at https://www.rxabbvie.com/pdf/botox_pi.pdf and discuss with your doctor.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.
References: 1. BOTOX® Prescribing Information, November 2023. 2. U.S. National Library of Medicine. National Institutes of Health (NIH). MedlinePlus website. http://www.nlm.nih.gov/medlineplus/ency/article/007259.htm. Updated June 7, 2023. Accessed January 10, 2025. 3. U.S. National Library of Medicine. National Institutes of Health (NIH). MedlinePlus website. http://www.nlm.nih.gov/medlineplus/ency/article/003218.htm. Updated June 20, 2023. Accessed January 10, 2025. 4. Solish N, Bertucci V, Dansereau A, et al. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg. 2007;33(8):908-923. 5. American Academy of Dermatology (AAD). Hyperhidrosis: Diagnosis and treatment. AAD website. https://aad.org/public/diseases/dry-sweaty-skin/hyperhidrosis. Accessed January 10, 2025. 6. International Hyperhidrosis Society. OnabotulinumtoxinA Injections (BOTOX®). International Hyperhidrosis Society website. https://sweathelp.org/hyperhidrosis-treatments/botox.html. Updated 2014. Accessed January 05, 2025.
;